At the same time, there were no significant differences in RPP40 expression between the two subgroups of BMI, residual tumor, tumor invasion, menopause status, hormone therapy, diabetes, radiation therapy, and surgical approach (Supplementary Figure 2). This evidence concerns the gene RPP40 and neoplasm.